Cytokinetics Total Liabilities and Share Holders Equity 2010-2024 | CYTK
Cytokinetics total liabilities and share holders equity for the quarter ending September 30, 2024 was $1.436B, a 93.9% increase year-over-year.
- Cytokinetics total liabilities and share holders equity for 2023 was $0.824B, a 18.77% decline from 2022.
- Cytokinetics total liabilities and share holders equity for 2022 was $1.015B, a 20.62% increase from 2021.
- Cytokinetics total liabilities and share holders equity for 2021 was $0.841B, a 57.61% increase from 2020.